NCT00199004View on ClinicalTrials.gov

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Adult Acute Lymphocytic Leukemia

Interventions

DRUG

Cyclophosphamide

DRUG

Dexamethasone / Prednisolone

DRUG

Vincristine

DRUG

Daunorubicin

DRUG

Asparaginase

DRUG

Methotrexate

DRUG

Cytarabine

DRUG

Mercaptopurine

DRUG

G-CSF

DRUG

Vindesine

DRUG

VP16

DRUG

Adriamycin

DRUG

Thioguanine

DRUG

VM26

DRUG

Rituximab

PROCEDURE

CNS irradiation

PROCEDURE

Mediastinal irradiation (if residual TU)

PROCEDURE

Stem cell transplantation

Trial Locations (1)

60590

University Hospital of Frankfurt, Medical Dept. II, Frankfurt

All Listed Sponsors

lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT00199004 - Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab | Biotech Hunter | Biotech Hunter